UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (4750) 4750
life sciences & biomedicine (4556) 4556
humans (3951) 3951
animals (2526) 2526
male (2083) 2083
dipeptidyl peptidase 4 - metabolism (1886) 1886
diabetes mellitus, type 2 - drug therapy (1641) 1641
female (1537) 1537
endocrinology & metabolism (1446) 1446
dipeptidyl-peptidase iv inhibitors - therapeutic use (1308) 1308
type 2 diabetes (1246) 1246
biological and medical sciences (1168) 1168
diabetes (1147) 1147
middle aged (1040) 1040
hypoglycemic agents - therapeutic use (971) 971
pharmacology & pharmacy (877) 877
rats (855) 855
mice (848) 848
dipeptidyl-peptidase iv inhibitors - pharmacology (844) 844
medical sciences (788) 788
biochemistry & molecular biology (774) 774
aged (760) 760
adult (711) 711
glucose (651) 651
dipeptidyl-peptidases and tripeptidyl-peptidases - metabolism (629) 629
diabetes mellitus, type 2 - blood (598) 598
analysis (582) 582
blood glucose - metabolism (576) 576
treatment outcome (561) 561
peptidase (523) 523
diabetes mellitus (522) 522
dipeptidyl peptidase 4 (512) 512
dipeptidyl-peptidase iv inhibitors - adverse effects (496) 496
fundamental and applied biological sciences. psychology (489) 489
peptides (484) 484
hypoglycemic agents (477) 477
adamantane - analogs & derivatives (471) 471
research (447) 447
dipeptidyl peptidase 4 - genetics (444) 444
insulin (435) 435
care and treatment (424) 424
blood glucose - drug effects (422) 422
cell biology (420) 420
dipeptidyl peptidase iv (413) 413
hypoglycemic agents - pharmacology (412) 412
dipeptidyl-peptidase iv inhibitors - administration & dosage (397) 397
drug therapy, combination (387) 387
hypoglycemic agents - adverse effects (386) 386
amino acid sequence (383) 383
glucagon (360) 360
dextrose (358) 358
enzymes (355) 355
proteins (352) 352
sitagliptin phosphate (349) 349
diabetes mellitus, type 2 - metabolism (346) 346
molecular sequence data (346) 346
risk factors (343) 343
drug therapy (338) 338
pharmacology. drug treatments (338) 338
sitagliptin (335) 335
abridged index medicus (332) 332
internal medicine (330) 330
immunology (324) 324
glycated hemoglobin a - metabolism (323) 323
diabetes therapy (321) 321
hypoglycemic agents - administration & dosage (318) 318
type 2 diabetes mellitus (312) 312
dipeptidyl peptidase 4 - blood (310) 310
dipeptidyl peptidase 4 - chemistry (310) 310
cardiovascular system & cardiology (304) 304
physiological aspects (302) 302
insulin resistance (299) 299
mice, inbred c57bl (294) 294
health aspects (290) 290
cells, cultured (288) 288
time factors (287) 287
diabetes mellitus, type 2 - complications (286) 286
metformin - therapeutic use (274) 274
medicine & public health (268) 268
glucagon-like peptide 1 - metabolism (265) 265
adamantane - therapeutic use (264) 264
chemistry (264) 264
dose-response relationship, drug (264) 264
endocrinopathies (263) 263
insulin - metabolism (263) 263
dipeptidyl-peptidase iv inhibitors (257) 257
double-blind method (255) 255
kinetics (255) 255
clinical trials (253) 253
research article (252) 252
diabetes. impaired glucose tolerance (249) 249
endocrine pancreas. apud cells (249) 249
gene expression (248) 248
proteases (248) 248
vildagliptin (248) 248
glucagon-like peptide 1 (246) 246
physical sciences (245) 245
disease models, animal (244) 244
medicine, research & experimental (242) 242
research & experimental medicine (242) 242
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5778) 5778
Japanese (49) 49
German (27) 27
Chinese (14) 14
Russian (13) 13
French (10) 10
Spanish (7) 7
Portuguese (6) 6
Czech (5) 5
Polish (5) 5
Croatian (3) 3
Hungarian (3) 3
Dutch (2) 2
Norwegian (2) 2
Danish (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature immunology, ISSN 1529-2908, 07/2015, Volume 16, Issue 8, pp. 850 - 858
Life Sciences & Biomedicine | Immunology | Science & Technology | Dipeptidyl Peptidase 4 - metabolism | Immunotherapy - methods | Male | Adoptive Transfer | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Cell Movement - immunology | Flow Cytometry | Lymphocytes - immunology | Neoplasms, Experimental - immunology | Chemokine CXCL10 - immunology | Neoplasms, Experimental - genetics | Female | Sitagliptin Phosphate | Dipeptidyl Peptidase 4 - immunology | Chemokines - immunology | Lymphocytes - metabolism | Receptors, CXCR3 - metabolism | Mice, Inbred C57BL | Neoplasms, Experimental - therapy | Dipeptidyl Peptidase 4 - genetics | Mice, Transgenic | Mice, Knockout | Triazoles - pharmacology | Cell Movement - drug effects | Animals | Receptors, CXCR3 - immunology | Cell Line, Tumor | Chemokines - metabolism | Mice, Inbred BALB C | Pyrazines - pharmacology | Chemokine CXCL10 - metabolism | Care and treatment | Usage | Immunotherapy | Development and progression | Inflammation | Health aspects | Chemokines | Tumors | Index Medicus | Neoplasms, Experimental/genetics | Immunotherapy/methods | Cell Movement/drug effects | Neoplasms, Experimental/therapy | Lymphocytes/metabolism | Lymphocytes/immunology | Dipeptidyl Peptidase 4/genetics | Life Sciences | Chemokine CXCL10/immunology | Pyrazines/pharmacology | Dipeptidyl Peptidase 4/immunology | Dipeptidyl-Peptidase IV Inhibitors/pharmacology | Chemokines/metabolism | Receptors, CXCR3/immunology | Receptors, CXCR3/metabolism | Neoplasms, Experimental/immunology | Triazoles/pharmacology | Cell Movement/immunology | Chemokines/immunology | Dipeptidyl Peptidase 4/metabolism | Chemokine CXCL10/metabolism
Journal Article
Drug metabolism and disposition, ISSN 0090-9556, 04/2007, Volume 35, Issue 4, pp. 533 - 538
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Pharmacology. Drug treatments | Medical sciences | Cytochrome P-450 CYP2C8 | Triazoles - administration & dosage | Dipeptidyl Peptidase 4 - metabolism | Triazoles - blood | Adenosine Deaminase - metabolism | Area Under Curve | Cytochrome P-450 CYP3A | Enzyme Inhibitors - blood | Humans | Microsomes, Liver - metabolism | Pyrazines - administration & dosage | Aryl Hydrocarbon Hydroxylases - genetics | Glycoproteins - metabolism | Cytochrome P-450 Enzyme System - metabolism | Male | Reference Values | Adenosine Deaminase Inhibitors | Sulfuric Acid Esters - metabolism | Enzyme Inhibitors - administration & dosage | Hypoglycemic Agents - blood | Kidney - metabolism | Glucuronides - metabolism | Enzyme Inhibitors - pharmacokinetics | Hypoglycemic Agents - administration & dosage | Biotransformation | Adult | Triazoles - pharmacokinetics | Molecular Structure | Sitagliptin Phosphate | Enzyme Inhibitors - urine | Triazoles - urine | Recombinant Proteins - metabolism | Hypoglycemic Agents - pharmacokinetics | Hydroxylation | Oxidation-Reduction | Administration, Oral | Glycoproteins - antagonists & inhibitors | Hypoglycemic Agents - urine | Pyrazines - urine | Aryl Hydrocarbon Hydroxylases - metabolism | Feces - chemistry | Cyclization | Pyrazines - pharmacokinetics | Dipeptidyl-Peptidase IV Inhibitors | Cytochrome P-450 Enzyme System - genetics | In Vitro Techniques | Pyrazines - blood | Carbon Radioisotopes | Index Medicus
Journal Article
Journal Article
Diabetes (New York, N.Y.), ISSN 0012-1797, 10/2005, Volume 54, Issue 10, pp. 2988 - 2994
Journal Article
Hypertension (Dallas, Tex. 1979), ISSN 0194-911X, 09/2012, Volume 60, Issue 3, pp. 833 - 841
Journal Article